Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

Collinson PO, van Dieijen-Visser MP, Pulkki K, Hammerer-Lercher A, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem. 2012 Jan;58(1):305-6. doi: 10.1373/clinchem.2011.171439. Epub 2011 Sep 27. No abstract available.

2.

How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study.

Collinson P, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen PH.

Clin Chem. 2008 Feb;54(2):448-9. doi: 10.1373/clinchem.2007.097501. No abstract available.

3.

Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: insights from CRUSADE.

Halim SA, Mulgund J, Chen AY, Roe MT, Peterson ED, Gibler WB, Ohman EM, Newby LK.

Circ Cardiovasc Qual Outcomes. 2009 May;2(3):199-206. doi: 10.1161/CIRCOUTCOMES.108.810127. Epub 2009 Apr 28.

4.

Clinical Inquiry: when you suspect ACS, which serologic marker is best?

Mitchell J, Mounsey A, Mackler L.

J Fam Pract. 2014 Feb;63(2):106-20. No abstract available.

PMID:
24527474
5.

A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study.

Pulkki K, Suvisaari J, Collinson P, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen P.

Clin Chem Lab Med. 2009;47(2):227-34. doi: 10.1515/CCLM.2009.044.

PMID:
19099527
6.

New features of troponin testing in different clinical settings.

Omland T.

J Intern Med. 2010 Sep;268(3):207-17. doi: 10.1111/j.1365-2796.2010.02253.x. Epub 2010 Jun 8. Review.

7.

Practice guideline for cardiac profiling.

Tietz NW.

Am J Clin Pathol. 1997 Dec;108(6):696-9. No abstract available.

PMID:
9384454
8.

Comparison of two clinical scoring systems for emergency department risk stratification of suspected acute coronary syndrome.

Macdonald SP, Nagree Y, Fatovich DM, Flavell HL, Loutsky F.

Emerg Med Australas. 2011 Dec;23(6):717-25. doi: 10.1111/j.1742-6723.2011.01480.x. Epub 2011 Aug 30.

PMID:
22151670
9.

Overcoming the challenges facing quality-improvement strategies for non-ST-segment elevation acute coronary syndromes.

Roe MT, Peterson ED, Ohman EM, Smith SC Jr, Gibler WB.

Am Fam Physician. 2004 Nov 15;70(10):1868, 1874, 1876. No abstract available.

10.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

11.

Troponin--past, present, and future.

Jaffe AS.

Curr Probl Cardiol. 2012 Jun;37(6):209-28. doi: 10.1016/j.cpcardiol.2012.02.002. Review.

PMID:
22548763
12.

For patients with acute coronary syndrome, is initial measurement of troponin alone the best we have to offer?

Nicolau JC, Furtado RH.

Arq Bras Cardiol. 2011 Jun;96(6):432-3. English, Portuguese, Spanish. No abstract available.

13.

[Redefinition of myocardial infarction--relevance of biomarkers].

Weber M, Hamm C.

Herz. 2008 Mar;33(2):115-21. doi: 10.1007/s00059-008-3103-7. Review. German.

PMID:
18344030
14.

Risk stratification in patients with unstable angina and non-ST segment elevation myocardial infarction: evidence-based review.

Doukky R, Calvin JE.

J Invasive Cardiol. 2002 Apr;14(4):215-20. Review. No abstract available.

PMID:
11923580
15.

Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.

Moffat KA, Ledford-Kraemer MR, Plumhoff EA, McKay H, Nichols WL, Meijer P, Hayward CP.

Thromb Haemost. 2009 Jan;101(1):178-84.

PMID:
19132206
16.

Practice guideline for cardiac profiling.

Karpas CM, White RM Sr.

Am J Clin Pathol. 1997 Dec;108(6):696; author reply 698-9. No abstract available.

PMID:
9384453
17.

The new definition of myocardial infarction: analysis of the ESC/ACC Consensus Document and reflections on its applicability to the Italian Health System.

Galvani M, Panteghini M, Ottani F, Cappelletti P, Chiarella F, Chiariello M, Crea F, Dolci A, Golino P, Greco C, Nicolosi GL, Plebani M, Tubaro M, Zaninotto M; Intersocietary Study Group "Markers of Myocardial Damage".

Ital Heart J. 2002 Sep;3(9):543-57.

PMID:
12407856
18.

The emerging role of highly sensitive troponin in the evaluation of acute coronary syndrome.

Mohammed AA, Januzzi JL Jr.

Compr Ther. 2009 Fall-Winter;35(3-4):167-76.

PMID:
20043613
19.

Japanese-Western consensus meeting on biomarkers.

Maisel AS, Nakao K, Ponikowski P, Peacock WF, Yoshimura M, Suzuki T, Tsutamoto T, Filippatos GS, Saito Y, Seino Y, Minamino N, Hirata Y, Mukoyama M, Nishikimi T, Nagai R.

Int Heart J. 2011;52(5):253-65. No abstract available.

20.

The discovery of troponin: its consequences and benefits.

Wilkinson E.

Eur Heart J. 2012 Jun;33(11):1294-5.

PMID:
22838021

Supplemental Content

Support Center